BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7544966)

  • 1. Multimodality treatment in advanced primary liver cancer.
    Zhou XD; Tang ZY; Yu YQ; Yang BH; Lu JZ; Lin ZY; Ma ZC
    Gan To Kagaku Ryoho; 1995 Aug; 22 Suppl 3():286-9. PubMed ID: 7544966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Long-term results of multimodality treatment in patients with primary liver cancer].
    Zhou X; Tang Z; Yu Y
    Zhonghua Wai Ke Za Zhi; 1996 Sep; 34(9):518-21. PubMed ID: 9594152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three decades' experience in surgery of hepatocellular carcinoma.
    Tang ZY; Yu YQ; Zhou XD; Yang BH; Lin ZY; Lu JZ; Ma ZC; Ye SL; Liu KD
    Gan To Kagaku Ryoho; 1997 May; 24 Suppl 1():126-33. PubMed ID: 9210895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of hepatocellular carcinoma: long-term outcome in 2639 cases.
    Zhou XD; Tang ZY
    Gan To Kagaku Ryoho; 1997 May; 24 Suppl 1():9-16. PubMed ID: 9210883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic artery ligation and infusion chemotherapy for unresectable primary liver cancer.
    Zhou XD; Tang ZY; Yu YQ; Ma ZC; Xu DB; Bao YM; Yang R; Zhang M; Zhou M
    Chin Med J (Engl); 1991 Oct; 104(10):846-50. PubMed ID: 1661226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of one hundred and twenty five patients with primary liver cancer surviving more than five years.
    Tang ZY; Yu YQ; Zhou XD; Ma ZC; Yang BH; Lu JZ; Lin HY; Tang CL
    Gan To Kagaku Ryoho; 1992 Jul; 19(8 Suppl):1202-6. PubMed ID: 1514834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Surgical treatment of primary liver cancer].
    Wu M; Chen H; Yao X
    Zhonghua Wai Ke Za Zhi; 1996 Dec; 34(12):707-10. PubMed ID: 9590765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Changing prognosis of primary liver cancer: some aspects to improve long-term survival].
    Zhou X; Tang Z; Yu Y
    Zhonghua Zhong Liu Za Zhi; 1996 May; 18(3):211-3. PubMed ID: 9387257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A study of treatment modalities for nonresectable primary liver cancer].
    Lin B; Li G; Yuan Y
    Zhonghua Zhong Liu Za Zhi; 1996 Jul; 18(4):310-3. PubMed ID: 9387331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hepatic artery ligation and intrahepatic arterial chemotherapy for nonresectable primary liver cancer].
    Zhou XD
    Zhonghua Wai Ke Za Zhi; 1991 Feb; 29(2):87-9, 141. PubMed ID: 1650684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downstaging followed by resection plays a role in improving prognosis of unresectable hepatocellular carcinoma.
    Tang ZY; Zhou XD; Ma ZC; Wu ZQ; Fan J; Qin LX; Yu Y
    Hepatobiliary Pancreat Dis Int; 2004 Nov; 3(4):495-8. PubMed ID: 15567731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Surgery-predominant comprehensive therapy for 134 patients with small hepatocellular carcinoma].
    Mo QG; Liang AM; Yang NW; Zhao YN; Yuan WP
    Ai Zheng; 2003 Feb; 22(2):189-91. PubMed ID: 12600298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Results of hepatic resection for 600 cases with primary liver cancer].
    Li G; Li J; Zhang Y
    Zhonghua Zhong Liu Za Zhi; 1995 Mar; 17(2):125-8. PubMed ID: 7656803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aggressive multimodality treatment for intra-hepatic recurrence of hepatocellular carcinoma following hepatic resection.
    Chan KM; Lee WC; Hung CF; Yu MC; Jan YY; Chen MF
    Chang Gung Med J; 2005 Aug; 28(8):543-50. PubMed ID: 16265844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Long-term prognosis after hepatic resection for huge primary liver cancer].
    Yuan YF; Li BK; Li JQ; Zhang YQ; Guo RP; Lin XJ; Li GH
    Ai Zheng; 2004 Jul; 23(7):821-4. PubMed ID: 15248920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term results of hepatic resection for hepatocellular carcinoma originating from the noncirrhotic liver.
    Chang CH; Chau GY; Lui WY; Tsay SH; King KL; Wu CW
    Arch Surg; 2004 Mar; 139(3):320-5; discussion 326. PubMed ID: 15006892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comprehensive therapy for primary liver cancer: a report of 607 cases].
    Liang AM; Mo QG; Yang NW; Zhao YN; Yuan WP
    Ai Zheng; 2004 Feb; 23(2):211-4. PubMed ID: 14960248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Results of multimodality therapy for unresectable primary liver cancer].
    Chen SG; Zhang SM; Zhao HT; Zhang N; Han K; Wang SB; Qu Q; Wei X; Rui J
    Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):709-12. PubMed ID: 17274382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Influence of different treatment modalities on survival of patients with two -stage resection of unresectable hepatocellular carcinoma].
    Fan J; Wu Z; Tang Z
    Zhonghua Wai Ke Za Zhi; 2001 Oct; 39(10):745-8. PubMed ID: 16201184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Multimodality treatment and two-stage resection for unresectable hepatocellular carcinoma--experimental and clinical studies].
    Tang ZY
    Zhonghua Zhong Liu Za Zhi; 1990 Jan; 12(1):2-5. PubMed ID: 2163821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.